The growing use of GLP-1 receptor agonists in weight management has transformed how healthcare and wellbeing practitioners approach obesity treatment. However, with this transformation comes the need for specialist knowledge and training to ensure these medications are prescribed, managed, and monitored safely.
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic the natural hormone GLP-1, helping regulate blood sugar and appetite. They have become an important part of evidence-based weight loss interventions.
Although GLP-1 therapies are highly effective for many patients, they are not suitable for everyone. Healthcare professionals require specialist training to:
• Identify appropriate candidates based on medical history and contraindications
• Manage potential side effects effectively
• Provide clear patient education around expectations
• Monitor long-term outcomes and adherence
• Ensure compliance with current healthcare guidelines
Training ensures practitioners remain compliant with CPD requirements while improving clinical confidence. At MJ Clinical Training, our CPD-accredited courses — including [GLP-1 Training](https://mjclinicaltraining.co.uk/courses/glp-1/) and [Medical Weight Loss Mastery](https://mjclinicaltraining.co.uk/courses/medical-weight-loss-mastery/) — equip practitioners with evidence-based knowledge and practical tools to deliver safe, effective care.
GLP-1 therapy often works best when delivered as part of a multi-disciplinary approach. Collaboration between pharmacists, GPs, nurses, nutritionists, and wellbeing practitioners ensures holistic patient support.
Practitioners should always rely on trusted sources such as the [NHS Obesity Guidance](https://www.nhs.uk/conditions/obesity/) and policies on [gov.uk](https://www.gov.uk/) when delivering GLP-1 therapy. Keeping up to date with evolving evidence and clinical guidelines is crucial for patient safety.
GLP-1 therapies have reshaped the landscape of medical weight management, but they require careful, informed delivery. Specialist training empowers practitioners to deliver these treatments safely, ethically, and effectively, ensuring patients receive the highest standard of care.
If you are a healthcare or wellbeing professional seeking to enhance your knowledge of GLP-1 therapies, explore our CPD-accredited training courses today. Contact us at info@mjclinicaltraining.co.uk, call 07769 003219, or visit our [contact page](https://mjclinicaltraining.co.uk/contact/).
1. What is GLP-1 training?
GLP-1 training is specialist education designed for healthcare and wellbeing professionals who deliver GLP-1 receptor agonist therapies. It covers patient assessment, safe prescribing, side effect management, and compliance with clinical guidelines.
2. Who should undertake GLP-1 training?
Any practitioner involved in weight management services — including pharmacists, nurses, GPs, and wellbeing specialists — should complete GLP-1 training to ensure they deliver treatments safely and effectively.
3. Why is specialist knowledge important when delivering GLP-1 therapy?
Specialist knowledge helps practitioners identify suitable patients, manage risks, and provide accurate education. Without it, patients may experience adverse outcomes or fail to achieve safe, sustainable weight loss.
4. Are GLP-1 therapies suitable for all patients?
No. Suitability depends on a patient’s medical history, current medications, and overall health. Proper training enables practitioners to screen for contraindications and avoid unsafe use.
5. What are the most common side effects practitioners need to manage?
Patients may experience nausea, vomiting, or gastrointestinal discomfort. Training ensures practitioners can support patients through these issues while recognising when further intervention is required.
6. How does GLP-1 training improve patient safety?
By equipping practitioners with evidence-based protocols, GLP-1 training reduces risks of inappropriate prescribing, ensures correct monitoring, and enhances informed consent and communication with patients.
7. Can non-medical wellbeing practitioners complete GLP-1 training?
Yes, provided they operate within their professional scope and work alongside medical colleagues where necessary. Training helps them understand how GLP-1 fits into broader weight management strategies.
8. How often should practitioners update their GLP-1 training?
Practitioners should refresh their knowledge regularly, ideally every 12–24 months, as new evidence, clinical guidelines, and safety updates emerge.
9. Does MJ Clinical Training provide CPD-accredited GLP-1 courses?
Yes. MJ Clinical Training offers CPD-accredited courses including [GLP-1 Training](https://mjclinicaltraining.co.uk/courses/glp-1/) and [Medical Weight Loss Mastery](https://mjclinicaltraining.co.uk/courses/medical-weight-loss-mastery/). These are designed to build competence and confidence in delivering weight management treatments.
10. Where can practitioners access trusted GLP-1 clinical guidelines?
Reliable guidance can be found through the [NHS Obesity Guidance](https://www.nhs.uk/conditions/obesity/) and policy updates from [gov.uk](https://www.gov.uk/), as well as CPD-accredited training providers like MJ Clinical Training.
As diaries fill with flights, train journeys and overnight stays, it’s common for patients on weekly GLP-1 therapy to worry that travel will break their
Every year as the festive season approaches, weight‑management clinics see the same pattern: routines loosen, social calendars fill, food environment cues multiply, and large meals
Obesity is one of the UK’s most urgent health challenges. Around two-thirds of adults in England are overweight or obese (NHS Digital) — and the
